CDH1 and sarcoma: To exclude the possibility that sarcomatoid tumours are in fact sarcomas arising from CRISPR/Cas9 targeted fibroblasts, we performed IHC staining of the epithelial marker cytokeratin 19 (CK19) and E-cadherin.